
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut Microbiota in Cancer Immune Response and Immunotherapy
Cheng‐Bei Zhou, Yilu Zhou, Jing‐Yuan Fang
Trends in cancer (2021) Vol. 7, Iss. 7, pp. 647-660
Closed Access | Times Cited: 213
Cheng‐Bei Zhou, Yilu Zhou, Jing‐Yuan Fang
Trends in cancer (2021) Vol. 7, Iss. 7, pp. 647-660
Closed Access | Times Cited: 213
Showing 26-50 of 213 citing articles:
Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine
Haitao Chen, Chenxiao Ye, Changhong Wu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2097-2113
Open Access | Times Cited: 24
Haitao Chen, Chenxiao Ye, Changhong Wu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2097-2113
Open Access | Times Cited: 24
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice
Yali Liu, Chi Chun Wong, Yanqiang Ding, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1467-1482
Open Access | Times Cited: 14
Yali Liu, Chi Chun Wong, Yanqiang Ding, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1467-1482
Open Access | Times Cited: 14
The role of the gut microbiota in tumor, immunity, and immunotherapy
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Gut microbiota and its therapeutic implications in tumor microenvironment interactions
Pengya Feng, Xia Xue, Ihtisham Bukhari, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 10
Pengya Feng, Xia Xue, Ihtisham Bukhari, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 10
Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
Xue Bai, Zhiguang Duan, Jianjun Deng, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Xue Bai, Zhiguang Duan, Jianjun Deng, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Shijiao Hou, Jiachen Yu, Yongshuang Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Shijiao Hou, Jiachen Yu, Yongshuang Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Yuqing Liu, Fan Li, Juanjuan Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Yuqing Liu, Fan Li, Juanjuan Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Maruhen Amir Datsch Silveira, Steve Bilodeau, Tim F. Greten, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 583-597
Open Access | Times Cited: 36
Maruhen Amir Datsch Silveira, Steve Bilodeau, Tim F. Greten, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 583-597
Open Access | Times Cited: 36
Faecal Microbiota Transplantation and Chronic Kidney Disease
Ji Bian, Ann Liebert, Brian Bicknell, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2528-2528
Open Access | Times Cited: 34
Ji Bian, Ann Liebert, Brian Bicknell, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2528-2528
Open Access | Times Cited: 34
Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State
Yanan Li, Zixuan Ye, Jianguo Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Yanan Li, Zixuan Ye, Jianguo Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
Xinxin Hou, Zongmei Zheng, Wei Jiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Xinxin Hou, Zongmei Zheng, Wei Jiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
The role of the sex hormone-gut microbiome axis in tumor immunotherapy
Luoyang Wang, Lei Tang, Dongchang Zhai, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Luoyang Wang, Lei Tang, Dongchang Zhai, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Oral administration of Manuka honey induces IFNγ-dependent resistance to tumor growth that correlates with beneficial modulation of gut microbiota composition
Razan J. Masad, Ienas Idriss, Yassir A. Mohamed, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Razan J. Masad, Ienas Idriss, Yassir A. Mohamed, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?
Jakub Makarewicz, Karolina Kaźmierczak-Siedlecka, Bartosz Kamil Sobocki, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Jakub Makarewicz, Karolina Kaźmierczak-Siedlecka, Bartosz Kamil Sobocki, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
The role of short-chain fatty acids in cancer prevention and cancer treatment
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 6
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 6
Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy
Marco Gargaro, Giorgia Manni, Giulia Scalisi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4644-4644
Open Access | Times Cited: 40
Marco Gargaro, Giorgia Manni, Giulia Scalisi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4644-4644
Open Access | Times Cited: 40
The Role of Gut Microbiota in Tumor Immunotherapy
Miao Wu, Jiawei Bai, Chengtai Ma, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 33
Miao Wu, Jiawei Bai, Chengtai Ma, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 33
Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism
Yiqing Gu, Qi Zheng, Guifang Fan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11042-11042
Open Access | Times Cited: 25
Yiqing Gu, Qi Zheng, Guifang Fan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11042-11042
Open Access | Times Cited: 25
Fermented natural product targeting gut microbiota regulate immunity and anti-inflammatory activity: A possible way to prevent COVID-19 in daily diet
Quancen Li, Na Li, Wenwen Cai, et al.
Journal of Functional Foods (2022) Vol. 97, pp. 105229-105229
Open Access | Times Cited: 23
Quancen Li, Na Li, Wenwen Cai, et al.
Journal of Functional Foods (2022) Vol. 97, pp. 105229-105229
Open Access | Times Cited: 23
The gut-lung axis in influenza A: the role of gut microbiota in immune balance
Guosen Ou, Huachong Xu, Jialin Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Guosen Ou, Huachong Xu, Jialin Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15